PRPH (STOCKS)
PROPHASE LABS INC
$0.127600
+0.021600 (+20.38%)
Prev close: $0.106000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Ted William Karkus
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.89M
- Employees
- 96
- P/E (TTM)
- -0.60
- P/B (TTM)
- 0.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-1.10 | $-1.53 | +0.4300 | +28.10% |
|
Mar 2025 (Q1)
|
$-1.40 | $-1.84 | +0.4360 | +23.75% |
|
Dec 2024 (Q4)
|
$-15.90 | $-2.45 | -13.4520 | -549.51% |
|
Sep 2024 (Q3)
|
$-3.50 | $0.41 | -3.9080 | -957.84% |
Financial Statements
| Revenues | $5.06M |
| Benefits Costs and Expenses | $39.44M |
| Cost Of Revenue | $4.07M |
| Costs And Expenses | $39.44M |
| Gross Profit | $2.06M |
| Operating Expenses | $30.60M |
| Depreciation and Amortization | $5.90M |
| Research and Development | $167.00K |
| Other Operating Expenses | $24.53M |
| Operating Income/Loss | -$29.61M |
| Income/Loss From Continuing Operations After Tax | -$49.56M |
| Income/Loss From Continuing Operations Before Tax | -$34.38M |
| Income/Loss From Discontinued Operations Net Of Tax | $7.86M |
| Income Tax Expense/Benefit | $15.18M |
| Net Income/Loss | -$41.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.78 |
| Diluted Earnings Per Share | -$1.78 |
| Basic Average Shares | 41,253,000 |
| Diluted Average Shares | 41,253,000 |
| Assets | $65.70M |
| Current Assets | $7.77M |
| Inventory | $266.00K |
| Other Current Assets | $7.51M |
| Noncurrent Assets | $57.93M |
| Intangible Assets | $7.81M |
| Non-current Prepaid Expenses | $140.00K |
| Other Non-current Assets | $49.98M |
| Liabilities | $58.84M |
| Current Liabilities | $55.29M |
| Noncurrent Liabilities | $3.55M |
| Equity | $6.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.86M |
| Liabilities And Equity | $65.70M |
| Net Cash Flow From Operating Activities | -$10.63M |
| Net Cash Flow From Operating Activities, Continuing | -$10.93M |
| Net Cash Flow From Operating Activities, Discontinued | $294.00K |
| Net Cash Flow From Investing Activities | $880.00K |
| Net Cash Flow From Investing Activities, Continuing | $80.00K |
| Net Cash Flow From Investing Activities, Discontinued | $800.00K |
| Net Cash Flow From Financing Activities | $9.66M |
| Net Cash Flow From Financing Activities, Continuing | $8.70M |
| Net Cash Flow From Financing Activities, Discontinued | $959.00K |
| Net Cash Flow | -$96.00K |
| Net Cash Flow, Continuing | -$2.15M |
| Net Cash Flow, Discontinued | $2.05M |
| Comprehensive Income/Loss | -$41.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$41.71M |
| Other Comprehensive Income/Loss | -$41.71M |